Foreign Cyberattack Cripples Major U.S. Newspapers

A cyberattack targeting the printing presses of several newspapers, delaying their delivery this weekend, appears to have originate from outside the U.S.

Late Delivery

This weekend, several of the most widely circulated newspapers in the United States found themselves the target of a cyberattack that reportedly originated on foreign soil.

Many questions about the attack remain unanswered, but one thing is certain: the media is under attack — and if something isn’t done to protect it, we could be headed toward a future in which we can’t believe anything we read.

Stop the Presses

The malware attack targeted newspaper printing plants run by The Los Angeles Times and Tribune Publishing, which owned The Los Angeles Times from April 2007 until June 2018 (and which, in a much-lampooned episode, briefly changed its name to Tronc in 2016.)

The malware prevented editors from transmitting pages of the papers to printing presses, and it delayed the scheduled printing and delivery of the Saturday editions of several newspapers, including The New York Times and The Wall Street Journal.

Nobody is sure of the source of the attack, but several people with inside knowledge of Tribune told The Los Angeles Times that the attack appeared to be Ryuk ransomware. Experts have linked this software to groups in North Korea and Eastern Europe, but for now, all The Los Angeles Times has confirmed is that the attack appears to have originated from outside the U.S.

Media Under Attack

As the name implies, ransomware attacks are typically financially motivated — attackers disrupt a company’s operations and demand a ransom to end the disruption — but neither Tribune Publishing nor The Los Angeles Times has reported any ransom demand. An anonymous source told The Los Angeles Times that the attackers didn’t appear to steal any information either.

That means a likely motivation behind the attack was preventing newspaper readers from getting their news — and that is highly troubling.

Just this month, the majority of Americans admitted for the first time that they prefer to get their news from social media platforms than from traditional print newspapers. While the latter sources are held to journalistic standards that place a premium on fact-checking and context, the former are notoriously rife with misinformation and bias.

If foreign actors are able to further cripple the U.S.’s already vulnerable newspaper industry by literally preventing the printing of newspapers, the “fake news” that dominates our social media feeds could one day overshadow the real news — and we’ve already gotten a glimpse of the disturbing impact that can have on a democracy.

READ MORE: Malware Attack Disrupts Delivery of L.A. Times and Tribune Papers Across the U.S. [The Los Angeles Times]

More on newspapers: For News, Americans Now Officially Prefer Social Media to Newspapers

The post Foreign Cyberattack Cripples Major U.S. Newspapers appeared first on Futurism.

Read more here:
Foreign Cyberattack Cripples Major U.S. Newspapers

Demand for Combustion Engine Cars May Have Peaked in 2018

combustion engine

No Sale

The reign of the fossil fuel-powered car may be ending.

In a report published on Sunday, several experts told the Financial Times that they believe sales of fossil fuel-powered internal combustion engine (ICE) vehicles peaked in 2018, meaning that it’s unlikely that more ICE cars will be sold in any future year— and if they’re correct, this epochal change in the auto industry could majorly benefit the environment.

Going Down

Many experts predicted at the beginning of 2018 that demand for ICE vehicles wouldn’t peak until 2022 at the earliest, according to the FT report. But a combination of several factors — including Brexit, the U.S.-China trade war, and new emissions targets in Europe — has dealt a major blow to global car sales this year.

“When you look at 2018 since the summer, new car sales in all of the important markets are going down,” Axel Schmidt, global automotive lead at Accenture, told FT. “Selling combustion engine cars to customers — this will not grow in the future.”

Even if overall car sales increase in 2019, ICE sales would likely fall thanks to the continued adoption of electric vehicles (EVs).

Road to Recovery

This might not be what ICEcar manufacturers want to hear, but it’s excellent news for the environment.

According to energy research group Wood Mackenzie, a mid-sized EV produces 67 percent fewer greenhouse gas emissions than a comparable gasoline-powered ICE vehicle. That figure doesn’t just take into account the emissions produced while the car is in use, either — it includes emissions caused by everything from electricity generation to crude oil refinement.

In 2016, transportation was the primary source of greenhouse gas emissions in the U.S., so if EVs continue to replace ICE cars in this nation and others, the world could significantly cut down on the climate-destroying emissions emanating from its roadways.

READ MORE: Combustion Engine Car Sales to Hit Peak Demand in 2018, Say Analysts [Financial Times]

More on ICE cars: These 7 Countries Want to Say Goodbye to Fossil Fuel-Based Cars

The post Demand for Combustion Engine Cars May Have Peaked in 2018 appeared first on Futurism.

See original here:
Demand for Combustion Engine Cars May Have Peaked in 2018

Scientist Who Gene Edited Babies Is Being Held By Mysterious Guards

Ball and chain.

Spotted

After Chinese scientist He Jiankui shocked the scientific community by announcing last month that he had edited the genes of human babies, he mysteriously vanished.

And now he’s been found. The New York Times reports that guards are holding He in a guesthouse at his university, the Southern University of Science and Technology. It’s unclear whether the guards work for the Chinese government, the university, or another organization — but their presence is the latest sign that He’s transgressive research upset the delicate balance of the genetics research community and regulatory systems, prompting retaliation from powerful interests.

Plainclothes Guards

The Chinese government condemned He’s work after he announced it, launching an investigation and banning him from continuing his research. What was unclear, however, was whether He’s disappearance was a result of him laying low or being held somewhere.

Now the Times has found that He is staying at a university guesthouse normally used to house visiting scholars, where a dozen plainclothes guards refused to identify themselves to a Times reporter. He is able to communicate over email and phone calls, according to the Times, and has corresponded with business colleagues.

“He was extremely irresponsible to the employees, partners and investors,” said Liu Chaoyu, with whom He co-founded the gene-testing company Vienomics, in an interview with the Times. Liu last saw He the day before the conference at which he disclosed the existence of the gene-edited babies. “He did not discuss anything with us before he made his announcement and we had to deal with all of it unexpectedly.”

Shock and Awe

The university and Shenzhen police both declined to comment to the Times. In fact, all employees of the university have been barred from speaking to the press, according to a message obtained by the paper.

What’s clear is that He’s unprecedented work sent shockwaves not just through the research ecosystem but through the powerful machinery of international government — and as the saga of his treatment in the wake of the announcement unfolds, it could be a roadmap to the challenges other researchers would face if they follow in his footsteps.

READ MORE: Chinese Scientist Who Claimed to Make Genetically Edited Babies Is Kept Under Guard [The New York Times]

More on He Jiankui: Chinese Scientists Claim to Have Gene-Edited Human Babies For the First Time

The post Scientist Who Gene Edited Babies Is Being Held By Mysterious Guards appeared first on Futurism.

Read more:
Scientist Who Gene Edited Babies Is Being Held By Mysterious Guards

Tiny Robots That Repair Pipes Could Eliminate Road Work

The U.K. is investing millions of dollars into the development of micro-robots capable of navigating and repairing underground pipes.

Micro-Robots

The road workers of the future could be smaller. And a lot less human.

On Monday, the United Kingdom’s Department for Business, Energy, and Industrial Strategy announced an $8.9 million investment into a project to develop micro-robots capable of inspecting and repairing the nation’s network of underground pipes.

If successful, the project could save the country billions of dollars annually — and change how road work gets done across the globe.

Pipe Dream

According to a government press release, a team of researchers from four U.K. universities will work together to develop the micro-robots, which will each be approximately just one-centimeter long. The goal is for these bots to fly, swim, or crawl through the pipes that transport water, gas, and sewage beneath U.K. streets.

One of the researchers working on the project, the University of Sheffield’s Kirill Horoshenkov, told The Daily Telegraph that the team plans to develop two versions of the robots.

One will be an “inspection bot” that can autonomously navigate and examine the pipes using sonar technology. The other will be a “worker bot” capable of repairing pipes using cement and adhesives or cleaning them with a high-powered jet. That robot will be slightly larger and steered via remote control.

According to Horoshenkov, the bots could be ready for use within five years.

Down the Road

Each year, 1.5 million road excavations take place in the U.K., and the traffic closures and business disruptions caused by this roadwork cost the nation an estimated $6.3 billion.

That means if this $8.9 million investment in the development of micro-robots pans out the way the U.K. is hoping, it’ll soon pay for itself many times over. There’s also the possibility of other nations adopting the same or similar tech after witnessing the U.K.’s success.

As U.K. Science Minister Chris Skidmore noted in the press release, “While for now we can only dream of a world without roadworks disrupting our lives, these pipe-repairing robots herald the start of technology that could make that dream a reality in the future.”

READ MORE: UK Invests in Micro-Robots Which Could Make Roadworks a Thing of the Past [The Telegraph]

More on micro-robots: Rolls-Royce Is Building Cockroach-Like Robots to Fix Plane Engines

The post Tiny Robots That Repair Pipes Could Eliminate Road Work appeared first on Futurism.

Excerpt from:
Tiny Robots That Repair Pipes Could Eliminate Road Work

Edible Coating Can Keep Food Fresh Longer and Cut Down on Waste

A new FDA-approved food coating can double a vegetable's shelf life. It may help reduce the $2 trillion cost and carbon emissions of food waste.

Greenhouse Gas

People waste a lot of food. In America alone, the National Resources Defense Council estimates that as much as 40 percent of the food people buy ends up in the trash, not to mention the perfectly-good food that never leaves the grocery store or even the farm.

The United Nations estimates that the world wastes 30 percent of all produced food, the total cost of which adds up to about $2.6 trillion. But the problem is bigger than an embarrassing misstep in your weekly budget — the methane emissions of all that rotting food are worse for the climate than if we had simply thrown that cash into the incinerator.

Slap a Fresh Coat on it

Since people struggle to avoid wasting all that food and the market for unsightly-but-good vegetables still isn’t there, a Californian startup called Apeel Sciences developed a thin, transparent, edible coating that can keep food fresh much longer than normal, according to CNBC.

The coating, Epideel, preserves food by preventing the two main causes of spoilage. Acting as a physical barrier, Epideel blocks the water in the food from evaporating away and also blocks atmospheric oxygen from reacting with the food. Reportedly, the coating can double the shelf life of notoriously finicky foods like avocados.

Big Strides

Epideel, which is made up of fats and other compounds taken from fruits and vegetables, was designed in accordance with “Generally Recognized as Safe” U.S. Food and Drug Administration regulations that allowed Apeel Sciences to circumvent the FDA’s normal approval process. Epideel-coated avocados are already on the shelves of grocery chains Kroger, Costco, and Harps Food.

Part of that success likely comes from the involvement of the Bill & Melinda Gates Foundation, which donated a sizable portion of the $110 million that Apeel Sciences has raised since its start back in 2012. The company has already found its way to CNBC‘s 2018 list of the top 50 disruptors, which highlights how CEO James Rogers hopes Epideel-coated foods can help feed the world’s hungry.

READ MORE: This Bill Gates-backed start-up is fighting world hunger by making your avocados last longer [CNBC]

More on food waste: Reducing Food Waste in Creative Ways Could Help the World’s Hunger Problem

The post Edible Coating Can Keep Food Fresh Longer and Cut Down on Waste appeared first on Futurism.

Go here to read the rest:
Edible Coating Can Keep Food Fresh Longer and Cut Down on Waste

Bill Gates: U.S. Leaders Must Embrace Nuclear Energy

Gates nuclear energy

Power Play

Think your New Year’s resolution to hit the gym is daunting? Microsoft co-founder Bill Gates wants to change an entire nation’s energy policy in 2019.

On Saturday, the billionaire philanthropist released a letter detailing what he learned in 2018 and what he hopes to accomplish in 2019. One of his goals for the next year is to persuade U.S. leaders to “get into the game” of advanced nuclear energy — and the future of our environment could be riding on his success.

Nuclear Option

Nuclear energy is produced by splitting the nucleus of an atom (fission) or combining the nuclei of two atoms (fusion). Nuclear fission reactors already meet 20 percent of the U.S.’s electricity needs. But while fission doesn’t produce greenhouse gas emissions, the technology is currently less than ideal — the U.S. built most of its reactors more than 30 years ago, and they require plutonium, which isn’t exactly easily accessible. The process also produces unwanted byproducts, some of which are radioactive.

Researchers have yet to figure out a way to produce stable nuclear fusion, but they’re getting closer. If — or, hopefully, when — they do succeed, we’ll have a near-limitless source of clean energy that we can create from hydrogen, which is far more accessible than plutonium, and the only byproduct would be a small amount of helium.

Worthy Investment

According to Gates, “Nuclear is ideal for dealing with climate change, because it is the only carbon-free, scalable energy source that’s available 24 hours a day.”

But the U.S. has been slacking off in terms of nuclear energy research in recent decades. To regain its position as a global nuclear energy leader it needs to “commit new funding, update regulations, and show investors that it’s serious,” wrote Gates.

He believes this renewed commitment will allow the nation to overcome the limitations of existing nuclear technology in a way that could significantly benefit the environment.

“The United States is uniquely suited to create these advances with its world-class scientists, entrepreneurs, and investment capital,” Gates wrote, later adding that the “world needs to be working on lots of solutions to stop climate change. Advanced nuclear is one, and I hope to persuade U.S. leaders to get into the game.”

READ MORE: As China Option Fades, Bill Gates Urges U.S. To Take the Lead in Nuclear Power, for the Good of the Planet [GeekWire]

More on nuclear energy: Nuclear Power Used to Seem Like the Future. Now Its Fate in the US Is in Question.

The post Bill Gates: U.S. Leaders Must Embrace Nuclear Energy appeared first on Futurism.

Link:
Bill Gates: U.S. Leaders Must Embrace Nuclear Energy

The EU Is Banning Almost All Coal Mining on Jan 1

Come January 1, all unprofitable coal mines in the European Union will be shut down. In Spain, that means 26 new closures.

No More Handouts

Every unprofitable coal mine in the European Union must cease production by the first day of 2019, the date on which all public funds for the mines will come to an end. In Spain, that means that 26 coal mines are about to close up shop, according to Reuters.

This move away from coal is a refreshing bit of bluntness — letting the failed remnants of a fossil fuel industry fade away — compared to how the federal government in the U.S. is grasping at anything to keep coal alive. But it remains to be seen how much of an impact the coal closures will have in the ongoing effort to curb climate change.

Always a Bigger Fish

The deadline was set back in 2010 as the EU sought to move away from fossil fuel dependence, according to Telesur. The EU wanted to end public aid to coal mines sooner, but groups from Germany — which shuttered its last coal mine earlier this month — and Spain are responsible for extending the deadline all the way to the end of 2018.

Spain has already decreased the portion of its electricity generated by coal down to about 14 percent, according to United Press International. And 90 percent of the coal burned in Spain is imported from Russia and Colombia anyway.

Still, the deal that Spain struck with the EU dictates that nine of the 15 coal-burning plants in Spain must close by 2020, according to Telesur. That on its own is huge news for the transition to cleaner power, and marks a clear sign that major world powers are taking their responsibility to help prevent our impending climate change catastrophe seriously.

Think Ahead

Once again in stark contrast to the U.S., where coal miners in Appalachia face a weak job market with few prospects, Spain’s socialist government — largely supported by coal mining communities — made a deal with mining union in October to ensure that displaced workers will be taken care of, according to Reuters.

About 60 percent of the people who worked in closing mines are expected to take advantage of an early retirement offer, while others have access to the 250 million euros that the government is making available to help launch new businesses or repurpose the land around the coal mines.

READ MORE: Spanish coal miners work last shifts before mines shuttered [Reuters]

More on coal: More Than 40 Percent of the World’s Coal Plants Lose Money

The post The EU Is Banning Almost All Coal Mining on Jan 1 appeared first on Futurism.

Read the original here:
The EU Is Banning Almost All Coal Mining on Jan 1

Stem Cell Treatment | Arizona | Stem Cell Rejuvenation Center

ADIPOSE STEM CELL THERAPIES AND TREATMENTS

PHOENIX ARIZONA | (602) 439-0000

WE PLAY AN ESSENTIALROLE IN IMPROVING THE LIVESOF PATIENTS FROM AROUND THE WORLD

For Immediate Assistance please fill out he form below:

TREATABLE CONDITIONS

HAVE GENERAL QUESTIONS

Please Note: Although we have supplied links to the research journals above on the use of stem cells for specific conditions, we are not saying that any of these studies would relate to your particular condition, nor that it would even be an effective treatment. OurAutologousStem Cell Therapy is not an FDA approved treatment for any condition. We provide stem cell therapy (less than manipulated) as a service &as a practice of medicine only. Please see theFAQ pagefor more information. Thesejournal articlesare for educational purposes only &are not intended to be used to sell or promote our therapy.

MAKING A POSITIVE IMPACT AROUND THE WORLD

2017 Stem Cell Rejuvenation Center

7600 N 15th St. Suite 102Phoenix, AZ 85020 USA

Telephone:(602) 439-0000Fax: (602) 439-0021

More here:

Stem Cell Treatment | Arizona | Stem Cell Rejuvenation Center

Stem Cell Therapy for Osteoarthritis – StemGenex

Stem Cell Therapy for Osteoarthritis

New treatments and advances in research are giving new hope to people affected by Osteoarthritis pain and symptoms. StemGenex provides stem cell therapy for Osteoarthritis to help those with unmet clinical needs achieve optimum health and better quality of life.

Stem cell therapy for Osteoarthritis is being studied for efficacy in improving the complications in patients through the use of their own stem cells. These procedures may help patients who dont respond to typical drug treatment, want to reduce their reliance on medication, or are looking to try stem cell therapy before starting drug treatment.

To learn more about becoming a patient and receiving stem cell therapy for Osteoarthritis through StemGenex, please contact one of our patient advocates at (800) 609-7795 or fill out the contact form on this page.Below are some frequently asked questions about stem cell treatment for Osteoarthritis.

The majority of complications in Osteoarthritis patients are related to the deterioration of cartilage that cushions the ends of bones in your joints. Cartilage is a firm, slippery tissue that permits nearly frictionless joint motion. In Osteoarthritis, this surface become rough. Eventually, if the cartilage wears down completely, patients will be left with bone rubbing on bone.

Stem cell treatment provided by StemGenex is designed to target these areas within the joints to help with the creation of new cartilage cells. Mesenchymal stem cells are multipotent and have the ability to differentiate into cartilage called (chondrytes). The goal of each stem cell treatment is to inject the stem cells into the joint to create cartilage (chondryte cells). Stem cells are a natural anti-inflammatories which can assist with Osteoarthritis pain and swelling in the joint area.

Stem cells are the basic building blocks of human tissue and have the ability to repair, rebuild, and rejuvenate tissues in the body. When a disease or injury strikes, stem cells respond to specific signals and set about to facilitate the healing process by differentiating into specialized cells required for the bodys repair.

There are four known types of stem cells which include:

StemGenex provides autologous adult stem cells (from fat tissue) where the stem cells come from the person receiving treatment.

StemGenex provides autologous adult adipose-derived stem cells (from fat tissue) where the stem cells come from the person receiving treatment.

We tap into our bodys stem cell reserve daily to repair and replace damaged or diseased tissue. When the bodys reserve is limited and as it becomes depleted, the regenerative power of our body decreases and we succumb to disease and injury.

Three sources of stem cells from a patients body are used clinically which include adipose tissue (fat), bone marrow and peripheral blood.

Performed by Board Certified Physicians, dormant stem cells are extracted from the patients adipose tissue (fat) through a minimally invasive mini-liposuction procedure with little to no downtime.

During the liposuction procedure, a small area (typically the abdomen) is numbed with an anesthetic and patients receive mild to moderate sedation. Next, the extracted dormant stem cells are isolated from the fat and activated, and then comfortably infused back into the patient intravenously (IV) and via other directly targeted methods of administration. The out-patient procedure takes approximately four to five hours.

StemGenex provides multiple administration methods for Osteoarthritis patients to best target the disease related conditions and symptoms which include:

Since each condition and patient are unique, there is no guarantee of what results will be achieved or how quickly they may be observed. According to patient feedback, many patients report results in one to three months, however, it may take as long as six to nine months. Individuals interested in stem cell therapy are urged to consult with their physician before choosing investigational autologous adipose-derived stem cell therapy as a treatment option.

In order to determine if you are a good candidate for adult stem cell treatment, you will need to complete a medical history form which will be provided by your StemGenex Patient Advocate. Once you complete and submit your medical history form, our medical team will review your records and determine if you are a qualified candidate for adult stem cell therapy.

StemGenex team members are here to help assist and guide you through the patient process.

Patients travel to StemGenex treatment center located in San Diego, California for stem cell treatment from all over the United States, Canada and around the globe. Treatment will consist of one visit lasting a total of three days. The therapy is minimally invasive and there is little to no down time. Majority of patients fly home the day after treatment.

We provide stem cell therapy for a wide variety of diseases and conditions for which traditional treatment offers less than optimal options. Some conditions include Multiple Sclerosis, Parkinson's Disease, Rheumatoid Arthritis, Osteoarthritis and Chronic Obstructive Pulmonary Disease (COPD).

The side effects of the mini-liposuction procedure are minimal and may include but are not limited to: minor swelling, bruising and redness at the procedure site, minor fever, headache, or nausea. However, these side effects typically last no longer than 24 hours and are experienced mostly by people with sensitivity to mild anesthesia. No long-term negative side effects or risks have been reported.

The side effects of adipose-derived stem cell therapy are minimal and may include but are not limited to: infection, minor bleeding at the treatment sites and localized pain. However, these side effects typically last no longer than 24 hours. No long-term negative side effects or risks have been reported.

StemGenex provides adult stem cell treatment with mesenchymal stem cells which come from the person receiving treatment. Embryonic stem cells are typically associated with ethical and political controversies.

Stem cell treatment is not FDA approved.

Stem cell for arthritis treatment is not covered by health insurance at this time. The cost for standard preoperative labs are included. Additional specific labs may be requested at the patients expense.

Osteoarthritis, or degenerative joint disease, is the most common type of arthritis. It is caused by the degradation of a joints cartilage. Cartilage is a firm, rubbery material that covers and cushions the ends of bones in normal joints. Its main function is to reduce friction in the joints and serve as an intermediary or cushion.

Over time, the cartilage may wear away in some areas, greatly decreasing its ability to act as a shock absorber. As the cartilage wears away, tendons and ligaments stretch, causing pain. In advanced cases, the bones could rub against each other, causing even more pain and loss of movement.

Osteoarthritis is very common in middle-aged and older people, and its symptoms can range from very mild to very severe. The disorder most often affects hands and weight-bearing joints such as knees, hips, feet and shoulders, but can affect almost any joint in the body.

View post:

Stem Cell Therapy for Osteoarthritis - StemGenex

Stem Cell Therapy for Anti-Aging and Sexual Performance …

Stem Cell Therapy has been around for quite some time, but due to high cost it was primarily used for recovery in athletes and the financial elite. However, with the progression of science and knowledge, stem cell therapy has become much more widely used and financially attainable.

Tampa Rejuvenation is the first in Tampa Bay to utilize the benefits of stem cell therapy for the purpose of anti-aging and sexual performance. We realize as our patients age, their bodies no longer have the regenerative properties to attain the desired results from using their growth factors alone as with our PRP, or Plasma Rich Platelet, therapy. Although many patients will still yield improvement with the PRP alone, the magnitude of cytokines and growth factors in your blood as you age will deplete with age. By implementing stem cell therapy, the number of growth factors are exponential allowing our bodies to regenerate on a magnitude that is otherwise unattainable with some results lasting for 3-5 years.

Stem Cell Therapy can be used to restore vitality to the skin, encourage the growth of hair, and even restore sexual performance and pleasure.

Go here to read the rest:

Stem Cell Therapy for Anti-Aging and Sexual Performance ...

NSI Stem Cell | What Is Stem Cell Therapy?

This innovative therapy option for alleviating pain and restoring function in the body could be the answer youve been looking for! We know you may have tried everything, and may have seen numerous doctors to take care of your condition, without real success. This can be very frustrating and can cause a lot of stress on you and your family. It is very important to your recovery to find someone that understands your journey and what you have been through along the way.

You may have been through the ringer with your injury or condition. Many of our patients have spent years getting their hopes up, and then getting their hopes dashed.

Stem Cell Therapy is about using your bodys own stem cells to regenerate damagedtissue. So if you, or someone you love, is suffering please read on to find out who can be helped and how.

Our Stem Cell Therapy is an innovative therapy that is recommendedfor a wide variety of chronic conditions, yet many people are learning about it now for the first time.

These are not embryonic stem cells or cells from fetuses.These regenerative cells come straight from your own body.

They are extracted just a few hours before theyre injected back into your body and put to work to heal damaged or dysfunctional tissue.

We use a variety of stem cells derived from the patients own tissues. Our preferred choice is bone marrow or fat because the cells there are multi-potent which means that they have the ability to differentiate into muscle, tendons, ligaments, bone, and cartilage. Once introduced into the damaged or diseased area, the stem cells can then heal your damaged tissue and regenerate new healthy tissue.

Stem Cell Therapy offers significant potential for the healing of tissues that have become injured as a result of the aging process.

See the article here:

NSI Stem Cell | What Is Stem Cell Therapy?

Stem Cell Therapy | Advanced Regenerative Orthopedics

Stem Cell Therapy involves the use of stem cells to stimulate the bodys natural repair mechanisms to repair, regenerate or replace damaged cells, tissues and organs. This physician-directed therapy is very safe, ethical and does not entail the use of any fetal or embryonic cells or tissue. It has been described as the future of medicine by many prestigious groups including the National Institutes of Health and the Institute of Medicine.

The field of Stem Cell Therapy continues to evolve, focusing on cures rather than just treatments for essentially all types of chronic diseases and conditions, including diabetes and cardiovascular disease, as well as various forms of arthritis and various orthopedic problems. When cells are transplanted into a patient, they do not stay for more than a few days. However, the cells provide a large and robust stimulus to turn on native repair mechanisms. The number of stem cells present in the body and their functional capacity to repair damaged tissue declines with each advancing decade of life, and chronic diseases further impede their ability to respond to chronic injury or damage in the body. This is why research has led to new solutions, which include the use of umbilical cord blood as the source of cells, which have the most potent ability to generate new tissues without risk of rejection. We at Advanced Regenerative Orthopedics use stem cells that are supplied by an FDA-registered cord blood bank.

Stem Cell Therapy and Tissue Engineering are much simpler and effective options that use very powerful young cells to stimulate the patients own native repair mechanisms to regenerate new cartilage and bone. The physician-directed treatment at ARO is a comprehensive approach to a specific joint with the goal of reducing the disabling pain and increasing function.

At Advanced Regenerative Orthopedics, our goal is to provide minimally invasive treatments along with regenerative techniques to target your bodys natural healing ability. Used as part of our innovative, three-tiered approach, physician-directed arthritis stem cell treatment can help patients of all ages get pain relief, increase their joint mobility and enjoy a higher quality of life.

Stem cell therapy can be an effective treatment for those suffering from a broad range of arthritic conditions. By using stem cells for arthritis, Advanced Regenerative Orthopedics stimulates your bodys natural mechanism to repair, regenerate and replace damaged cells within your joints.

If you live in Tampa, Brandon, St. Petersburg, Clearwater, Lakeland, Sarasota, The Villages, Ocala, or the surrounding areas and are interested in learning more about using stem cells for arthritis or any other joint condition, please contact our courteous and efficient office staff today to schedule an appointment. We look forward to discussing the benefits of physician-directed arthritis stem cell treatment with you and determining the best course of treatment to restore your joint health.

As many of our patients travel to us from outside the state of Florida for our world class procedures, our team is very familiar with managing the care & travel for remote patients.

See the original post here:

Stem Cell Therapy | Advanced Regenerative Orthopedics

Stem Cell Therapy for Arthritis

Experts are researching ways to use stem cells to treat arthritis in the knee and other joints. Many doctors already use stem cell therapy to treat arthritis, but it is not considered standard practice.

Stem cell therapy is one of several non-surgical treatments for arthritis pain. See Knee Osteoarthritis Treatment

There is a lot of debate around stem cell treatment, and it is helpful for potential patients to understand what stem cells are and the issues surrounding their use in arthritis therapy.

Article continues below

Stem cells are located throughout the body. What makes stem cells special is that they can:

See What Are Stem Cells?

Advocates of stem cell treatments hypothesize that, when placed into a certain environment, stem cells can transform to accommodate a certain need. For example, stem cells that are placed near damaged cartilage are hypothesized to develop into cartilage tissue.

See What Is Cartilage?

Stem cells can be applied during a surgery (such as the surgical repair of a torn knee meniscus) or delivered through injections directly into the arthritis joint.

Watch: Knee Meniscus Tear Video

When administering stem cell injections, many physicians use medical imaging, such as ultrasound, in order to deliver cells precisely to the site of cartilage damage.

The most common type of stem cells used for treating arthritis are mesenchymal stem cells. Mesenchymal stem cells are usually collected from the patients fat tissue, blood, or bone marrow.

The process of collecting cells is often called harvesting.

Bone marrow is usually taken from the pelvic bone using a needle and syringe, a process called bone marrow aspiration. The patient is given a local anesthetic and may also be given a sedative before the procedure.

There are no professional medical guidelines for who can and cannot receive stem cell therapy for arthritis. For now, the decision about who gets stem cell therapy is up to patients and doctors.

See Arthritis Treatment Specialists

There is some evidence that people with severe arthritis can benefit from stem cell therapy.1 Most research indicates that younger patients who have relatively mild osteoarthritis or cartilage damage see the most benefit.2

See What Is Osteoarthritis?

Some doctors have certain criteria for recommending stem cell therapy. For example, they only recommend it to patients who are healthy and have relatively little cartilage damage. Other doctors make recommendations on a case-by-case basis.

Stem cell therapy is a promising but still unproven treatment, and will not be covered by most insurance companies.

Complete Listing of References

Read the rest here:

Stem Cell Therapy for Arthritis

National Stem Cell Centers | Stem Cell Therapy in New York …

At National Stem Cell Centers, our affiliate physicians focus on leading edge, regenerative medicine. Instead of synthetic compounds, prescription medications, or surgical procedures, they activate your own natural cellular resources to promote healing.

Our goal is to allow patients access to this potentially revolutionary form of treatment to harness your bodys natural healing cascade mechanism for the repair of damaged tissues.

Adult mesenchymal stem cells are a form of undifferentiated cells. These kinds of stem cells are found in great abundance within abdominal adipose (fatty) tissue and bone marrow. Lying dormant (non-replicating), these remarkably intelligent cells can be activated to become other kinds of cells specific to tendons, muscle, blood vessels, nerves, and bone.

This means that regenerative cell therapies can be helpful in reducing pain, chronic inflammation, and the mitigation of some degenerative disease states.

At National Stem Cell Centers, our affiliated physicians utilize autologous stem cells harvested from your own tissue, without any form of artificial cellular manipulation, enzymes, expansion or multiplication.

Conditions Addressed

Anecdotal evidence including patient feedback suggests that stem cell procedures may be helpful in addressing conditions and injuries such as joint pain including knee pain, arthritis, osteoarthritis, back pain, and chronic inflammation.

As technology evolves, autoimmune and neurological disorders, orthopedic and urological conditions, heart and lung diseases, erectile dysfunction (ED), hair loss, cellular rejuvenation, autism, and aesthetics could be addressed as well.

Why National Stem Cell Centers?

There are many reasons you should choose our affiliated physicians including:- Our doctors are surgeons, not ordinary physicians- FDA registered tissue processing lab- No multiplication/duplication/expansion of cells- Numerous happy patients as evidenced by our 5 Star Reviews- IND and IRB Applications in preparation- Initiating participation in clinical trials- Affordable prices- Zero percent financing

Call today to find out if you are a candidate and to schedule a complimentary consultation. National Stem Cell Centers has affiliate physicians in New York City, Great Neck, Hauppauge and Southampton, Long Island, New Jersey, Dallas and Houston in Texas, and Newport Beach, California.

See the original post here:

National Stem Cell Centers | Stem Cell Therapy in New York ...

Is Stem Cell Therapy Covered by Medicare?

Stem cell therapy has been a hot topic in the press lately. With more and more medical providers offering stem cell treatments, patients around the country have been wondering, Is Stem Cell Therapy covered by Medicare.

Stem Cell research has shown that its an effective treatment for chronic joint pain and arthritis sufferers and more recent studies are starting to show the benefit for treatment of neurological disorders as well. (M.S., Parkinsons, and Stroke)

So the team at Stem Cell: The Magazine, have put together some information to answer this question of insurance coverage for potential medical enrollees seeking stem cell and regenerative treatments.

So what is the answer to Does Medicare cover Stem Cell therapy?

From the research that we have pulled up regarding Medicare Insurance Coverage for stem cell therapy; medicare does cover stem cell treatments, but not for some of the chronic degenerative conditions that regenerative treatments (stem cell therapy) can help them with.

You can see in this publication from BCBS that stem cell therapy is covered for the following conditions:

INDICATIONS FOR COVERAGE

Section 2.aAllogeneic Hematopoietic Stem Cell Transplantation (HSCT) eligible for coverage in the following:a) The treatment of leukemiab) The treatment of severe combined immunodeficiency disease (SCID) and for the treatment of Wiskott-Aldrich syndrome.ORc) The treatment of Myelodysplastic Syndromes (MDS) pursuant to Coverage with Evidence Development (CED) in the context of a Medicare-approved, prospective clinical study.3. Autologous Stem Cell Transplantation(AuSCT) is eligible for coverage in the following:a) Acute leukemia in remission who have a high probability of relapse and whohave no human leucocyte antigens (HLA)-matched;ORb) Resistant non-Hodgkins lymphomas or those presenting with poor prognosticfeatures following an initial response;ORc) Recurrent or refractory neuroblastoma;ORd) Advanced Hodgkins disease who have failed conventional therapy and have no HLA-matched donor.

You can see that outside of the listed conditions above, Medicare does not cover stem cell therapy for treatments joint conditions or neurological conditions that patients are more commonly seeking treatment for.

In this article, it clearly states that stem cell therapy for the coverage of orthopedic conditions is not covered:

The orthopedic application of stem-cell therapy is not addressed within the stem cell transplantation NCD. (NCD = National Care Determinations)

What this means for any patient that is looking to receive regenerative and stem cell treatments for orthopedic conditions such as:

M

M

Download our free Stem Cell 101 educational report now!

Medicare will not cover treatment for these conditions. In fact, most major medical carriers will not provide coverage for these treatments either.

Many chronic joint pain sufferers wonder why Medicare and most major carriers dont provide coverage for these treatments if they are so effective, but there is a simple answer for why this is.

Medicare and most major health insurance are for emergency conditions. Regenerative medicine is still considered an elective treatment, close to wellness care. Insurance carriers are not in the business of providing wellness for coverage for their participants.

We found a great video that explains more about this by John R Hoffman at Arcadia University. In it he describes the challenges of Medicare coverage for Stem Cell Therapy.

Our hope at Stem Cell: The Magazine is that as more and more patients continue to seek out treatment of their orthopedic and neurological conditions using stem cell and regenerative treatments, that Mediare and major health insurances will accept stem cell as the first treatment for these chronic conditions.

Learn More About Stem Cell Therapy

Is Stem Cell Therapy Covered by Medicare? was last modified: October 3rd, 2018 by Stem Cell The Magazine

See the original post here:

Is Stem Cell Therapy Covered by Medicare?

Stem Cell Basics I. | stemcells.nih.gov

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

Until recently, scientists primarily worked with two kinds of stem cells from animals and humans: embryonic stem cells and non-embryonic "somatic" or "adult" stem cells. The functions and characteristics of these cells will be explained in this document. Scientists discovered ways to derive embryonic stem cells from early mouse embryos more than 30 years ago, in 1981. The detailed study of the biology of mouse stem cells led to the discovery, in 1998, of a method to derive stem cells from human embryos and grow the cells in the laboratory. These cells are called human embryonic stem cells. The embryos used in these studies were created for reproductive purposes through in vitro fertilization procedures. When they were no longer needed for that purpose, they were donated for research with the informed consent of the donor. In 2006, researchers made another breakthrough by identifying conditions that would allow some specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state. This new type of stem cell, called induced pluripotent stem cells (iPSCs), will be discussed in a later section of this document.

Stem cells are important for living organisms for many reasons. In the 3- to 5-day-old embryo, called a blastocyst, the inner cells give rise to the entire body of the organism, including all of the many specialized cell types and organs such as the heart, lungs, skin, sperm, eggs and other tissues. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease.

Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. However, much work remains to be done in the laboratory and the clinic to understand how to use these cells for cell-based therapies to treat disease, which is also referred to as regenerative or reparative medicine.

Laboratory studies of stem cells enable scientists to learn about the cells essential properties and what makes them different from specialized cell types. Scientists are already using stem cells in the laboratory to screen new drugs and to develop model systems to study normal growth and identify the causes of birth defects.

Research on stem cells continues to advance knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Stem cell research is one of the most fascinating areas of contemporary biology, but, as with many expanding fields of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries.

I.Introduction|Next

Read more here:

Stem Cell Basics I. | stemcells.nih.gov

Regenexx Stem Cell Procedures | 100% Non-Surgical Pain Treatment

Stem Cell Therapy Facts & Information

Stem Cell Therapyas an alternative solution to invasive surgery for patients suffering from a wide range of degenerative conditions and injuries including:

The Regenexx Stem Cell Therapy protocol produces the highest stem cell concentrations possible. All procedures utilize advanced imaging guidance to ensure the stem cells are delivered precisely to the area in need to assist healing in the damaged tissues.

Our bodys stem cells are responsible for healing us. However, as we age or sustain injury, we sometimes cannot get enough of these healing cells into the injured area. Stem Cell Therapy solves this problem by harvesting the patients own cells and then injecting them directly into the area in need. These cells can assist in the healing of damaged tissue, tendons, ligaments, cartilage and bone while decreasing downtime and avoiding painful rehabilitation periods typically associated with surgery. In a series of three injections spaced roughly two to five days apart, the patient can be well on their way to a full recovery.

TheStem Cell Therapy protocol is a series of three procedures that happen over the course of several days.

PRE-INJECTION: A dextrose solution that stimulates surrounding soft tissue & prepares it for stem cell procedure.

SAME-DAY STEM CELL PROCEDURE: In the morning, blood and bone marrow samples are taken. Later that day, stem cells and blood platelets are introduced into the injury site.

POST-INJECTION: Additional platelet stimulants are introduced to invigorate stem cells and boost healing process.

Stem Cell Therapy is intended to help your body actually heal injured tissue. Initial improvement and reduction in pain may be experienced very quickly, with continued improvement as the healing progresses. Patient studies have shown Stem Cell Therapy to be very effective at relieving pain, while MRI images have confirmed successful tissue repair following stem cell therapy. The need for surgery can be greatly reduced by treating injured tissues before the damage progresses and the condition is irreversible.

Have you been diagnosed with one the following:

Are you currently experiencing:

Continue reading here:

Regenexx Stem Cell Procedures | 100% Non-Surgical Pain Treatment

Stem Cell Therapy for Knee Injuries and Arthritis

Utilizing your own stem cells to help the healing process of injured or degenerated jointsThe human body is made of billions of specialized cells that form specific organs like the brain, skin, muscles, tendons, ligaments, joints, and bone. Each day these cells go through a degenerative and regenerative process. As older cells die, new cells are born from stem cells with the unique capability of being able to create multiple types of other cells. However, when tissues are injured, the degenerative process exceeds this regenerative process, resulting in structures that become weaker, painful and less functional. While there are several types of stem cells, those that are best at promoting musculoskeletal healing (tendon, ligament, cartilage and bone) are found in bone marrow. These mesenchymal stem cells, or MSCs, are essential to successful patient outcomes and at Stem Cell ARTS we utilize the patented Regenexx Stem Cell Protocol, which iscapable of yielding much higher concentrations of these important cells.Most Commonly Treated Knee Conditions and InjuriesBelow is a list of the most common knee injuries and conditions that we treat with stem cells or platelet procedures. This is not an all-inclusive list.Knee Patient Outcome Data

This Regenexx bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry.

Regenexx has published more data on stem cell safety in peer reviewed medical research for orthopedic applications than any other group world-wide. This is a report of 1,591 patients and 1,949 procedures treated with the Regenexx Stem Cell Procedure. Based on our analysis of this treatment registry data, the Regenexx Stem Cell Procedure is about as safe as any typical injection procedure, which is consistent with what we see every day in the clinic.

To use, begin playing the first video. Then use the Playlist Dropdown Menu in the upper left corner of the video display to show all video titles. Use the Scroll Bar on the right hand side of the playlist to browse all video titles if required.

These non-surgical stem cell injection procedures happen within a single day and may offer a viable alternative for those who are facing surgery or even joint replacement. Patients are typically able to return to normal activity following the procedure and are able to avoid the painful and lengthy rehabilitation periods that are typically required to help restore strength, mobility and range-of-motion following invasive joint surgeries. Lastly, patients are far less vulnerable to the risks of surgeries, such as infection and blood clots.

Modern techniques in todays medicine allows us to withdraw stem cells from bone marrow, concentrate them through a lab process and then re-inject them precisely into the injured tissues in other areas of the body using advanced imaging guidance. Through Fluoroscopy and MSK Ultrasound, were able to ensure the cells are being introduced into the exact area of need. When the stem cells are re-injected, they enhance the natural repair process of degenerated and injured tendons, ligaments, and arthritic joints Turning the tables on the natural breakdown process that occurs from aging, overuse and injury.

If you are suffering from a joint injury or degenerative condition such as osteoarthritis, you may be a good candidate for a stem cell procedure. Please complete the form below and we will immediately send you an email with additional information and next steps in determining whether youre a candidate for these advanced stem cell procedures.

View original post here:

Stem Cell Therapy for Knee Injuries and Arthritis

Stem Cell Therapy in Richmond Start Healing Chronic Pain …

Stem cell therapy is a targeted treatment that activates your bodys own natural ability to heal and regenerate. With a simple in-office procedure you will improve your quality of life and potentially avoid surgery.

Research continues to show an increasing number of potential benefits from the anti inflammatory, immunomodulatory, and regenerative actions of stem cells. Stem cell therapy treats pain and chronic conditions at their source, returning you to the things you enjoy.

Our stem cell therapy treatment utilizes umbilical cord derived Mesenchymal Stem Cells from FDA regulated cord banks. Mesenchymal Stem Cells are specialized cells that are able to receive signals from the other cells in your body. Stem cells then seek out inflammation and degeneration and go to that location to begin repairing tissue.

Stem cells have been shown to help repair muscle, bone, cartilage and tendons. Research has indicated that stem cells can benefit a wide variety of health complications and may assist in individuals living stronger, healthier lives.

Our mission is simple: Change the lives of our patients by providing an integrative, holistic approach to healing.

We help people suffering from chronic health conditions, chronic pain, autoimmune issues, and many other undiagnosed syndromes and health problems.

We are passionate about caring for our patients who, until now, were not able to find answers and treatments for their underlying health issues.

Regenerative medicine through stem cell therapy is the future of health care and, for our patients, THE FUTURE IS NOW!

Are you a candidate for regenerative stem cell therapy? The answer is YES if you suffer from any of the following:

Were here to help you heal and restore your health today! Please contact us now using the form below to explore how stem cell therapy can help you find relief and embrace your life again!

Read more:

Stem Cell Therapy in Richmond Start Healing Chronic Pain ...

The Power of Stem Cells | California’s Stem Cell Agency

En Espaol

Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating diseaseand what hurdles experts face before new therapies reach patients.

How can stem cells treat disease?What diseases could be treated by stem cell research?How can I learn more about CIRM-funded research in a particular disease?What cell therapies are available right now?When will therapies based on embryonic stem cells become available?What about the therapies that are available overseas?Why does it take so long to create new therapies?How do scientists get stem cells to specialize into different cell types? How do scientists test stem cell therapies?Can't stem cell therapies increase the chances of a tumor?Is there a risk of immune rejection with stem cells?How do scientists grow stem cells in the right conditions?

When most people think about about stem cells treating disease they think of a stem cell transplant.

In a stem cell transplant, embryonic stem cells are first specialized into the necessary adult cell type. Then, those mature cells replace tissue that is damaged by disease or injury. This type of treatment could be used to:

But embryonic stem cell-based therapies can do much more.

Any of these would have a significant impact on human health without transplanting a single cell.

In theory, theres no limit to the types of diseases that could be treated with stem cell research. Given that researchers may be able to study all cell types via embryonic stem cells, they have the potential to make breakthroughs in any disease.

CIRM has created disease pages for many of the major diseases being targeted by stem cell scientists. You can find those disease pages here.

You can also sort our complete list of CIRM awards to see what we've funded in different disease areas.

Many clinical trials for embryonic stem cell-based therapies have begun in recent years. Results from those won't be available until the trials reveal that the therapies are safe and effectivewhich could take a few years.

While ten cell therapies have been approved around the world as of January 2016, the only widely used stem cell-based therapy is bone marrow transplantation. Blood-forming stem cells in the bone marrow were the first stem cells to be identified and were the first to be used in the clinic. This life-saving technique has helped thousands people worldwide who had been suffering from blood cancers, such as leukemia.

In addition to their current use in cancer treatments, research suggests that bone marrow transplants will be useful in treating autoimmune diseases and in helping people tolerate transplanted organs.

Other therapies based on adult stem cells are currently in clinical trials. Until those trials are complete we won't know which type of stem cell is most effective in treating different diseases.

There is no way to predict when the first human embryonic stem cell therapies will become widely available. Several applications with the FDA to begin human trials of embryonic stem cell-based therapies have been approved. In general, the path from the first human trial to widespread use is on the order of a decade. That long time frame is a result of the many steps a therapy must go through in order to show that it is both safe and effective. Only once those steps are complete will the FDA approve the therapy for general use.

If embryonic stem cells follow a normal path it could still be many years before therapies based on embryonic stem cells are widely available. However, if researchers gave up on therapies simply because the path towards FDA approval is long, we would not have any of the lifesaving technologies that are now commonplace: recombinant insulin, bone marrow transplantation or chemotherapy drugs.

Find Out More:Read the top ten things to know about stem cell treatments (from ISSCR) Alan Lewis talks about getting an embryonic stem cell-based therapy to patients (3:46)

Many overseas clinics advertise miraculous stem cell therapies for a wide range of incurable diseases. This phenomenon is called stem cell tourism and is currently a source of concern for reputable stem cell scientists. International (and even domestic) clinics are offering up therapies that have not been tested for safety or even for effectiveness. In the past few years, some patients who visited those clinics have died as a result of receiving unproven, untested stem cells.

Find Out More:Learn more about the issue on our StemCell Tourism page. Jeanne Loring discusses concerns about stem cell tourism (3:38) CIRM/ISSCR panel on stem cell tourism

Embryonic stem cells hold the potential to treat a wide range of diseases. However, the path from the lab to the clinic is a long one. Before testing those cells in a human disease, researchers must grow the right cell type, find a way to test those cells, and make sure the cells are safe in animals before moving to human trials.

Find Out More:Hans Keirstead talks about hurdles in developing a new therapy (5:07)

One of the biggest hurdles in any embryonic stem cell-based therapy is coaxing stem cell to become a single the cell type. The vital process of maturing stem cells from a pluripotent state to an adult tissue type is called differentiation.

Guiding embryonic stem cells to become a particular cell type has been fraught with difficulty. Normally, stem cells growing in a developing embryo receive a carefully choreographed series of signals from the surrounding tissue. In a lab dish, researchers have to mimic those signals. Add the signals in the wrong order or the wrong dose and the developing cells may choose to remain immatureor become the wrong cell type

Many decades of research has uncovered many of the signals needed to properly differentiate cells. Other signals are still unknown. Many CIRM-funded researchers are attempting to differentiate very pure populations of mature cell types that can accelerate therapies.

Find Out More:Mark Mercola talks about differentiating cells into adult tissues (3:37)

Once a researcher has a mature cell type in a lab dish, the next step is to find out whether those cells can function in the body. For example, embryonic stem cells that have matured into insulin-producing cells in the lab are only useful if they continue producing insulin once transplanted inside a body. Likewise, researchers need to know that the cells can integrate into the surrounding tissue.

Scientists test cells by first developing an animal model that mimics the human disease, and then implanting the cells to see if they help treat the disease. These types of experiments can be painstakingbecause even if the cells dont completely cure the disease, they may restore some functions that would still be of enormous benefit to people. Researchers have to examine each of these possible outcomes.

In many cases testing the cells in a single animal model doesnt provide enough information. Most animal models of disease dont perfectly mimic the human disease. For example, a mouse carrying the same mutation that causes cystic fibrosis in humans doesnt show the same signs as a person with the disease. So, a stem cell therapy that treats this mouse model of cystic fibrosis may not work in humans. Thats why researchers often need to test the cells in more than oneanimal model.

The promise of embryonic stem cells is that they can form any type of cell in the body. The trouble is that when implanted into an animal they do just that, in the form of tumors called teratomas. These tumors consist of a mass of many cells types and can include hair cells and many other tissues.

These teratomas are one reason why it is necessary to mature the embryonic stem cells into highly purified adult cell types before implanting into humans. Virtually all evidence has shown that the mature cells are restricted to their one identity and dont appear to revert to a teratoma-forming cell.

Find Out More:UC Davis researcher focuses on stem cell safety (from UC Davis)Paul Knoepfler talks about the tendency of embryonic stem cells to form tumors (4:10)

Transplanted stem cells, like any transplanted organ, can be recognized by the immune system as foreign and then rejected. In organ transplants such as liver, kidney, or heart, people must be on immune suppressive drugs for the rest of their lives to prevent the immune system from recognizing that organ as foreign and destroying it.

The likelihood of the immune system rejecting a transplant of embryonic stem cell-based tissue depends on the origin of that tissue. Stem cells isolated from IVF embryos will have a genetic makeup that will not match that of the person who receives the transplant. That persons immune system will recognize those cells as foreign and reject the tissue unless a person is on powerful immune suppressive drugs.

Stem cells generated through SCNT or iPS cell technology, on the other hand, are a perfect genetic match. The immune system would likely overlook that transplanted cells, seeing it as a normal part of the body. Still, some suggest that even if the cells are perfectly matched, they may not entirely escape the notice of the immune system. Cancer cells, for example, have the same genetic make up as surrounding tissue and yet the immune system will often identify and destroy early tumors. Until more information is available from animal studies it will be hard to know whether transplanted patient-specific cells are likely to call the attention of the immune system.

Find Out More: Jeffrey Bluestone talks about immune rejection of stem cell-based therapies (4:05)

In order to be approved by the FDA for use in human trials, stem cells must be grown in good manufacturing practice (GMP) conditions. Under GMP standards, a cell line has to be manufactured so that each group of cells is grown in an identical, repeatable, sterile environment. This ensures that each batch of cells has the same properties, and each person getting a stem cell therapy gets an equivalent treatment. Although the FDA hasnt yet issued guidelines for how pluripotent stem cells need to meet GMP standards, achieving this level of consistency could mean knowing the exact identity and quantity of every component involved in growing the cells.

Updated 2/16

Read more:

The Power of Stem Cells | California's Stem Cell Agency